Psyence Biomedical Ltd.
PBM
NASDAQ Capital Market3.06
USD
+0.02
- -
Total Valuation
Psyence Biomedical Ltd. carries a market capitalization of 58,198.00, placing it among publicly traded companies globally.
| Market Cap | 58,198.00 |
| Enterprise Value | N/A |
Stock Price Statistics
Psyence Biomedical Ltd.'s stock has declined approximately -89.59184% over the past 52 weeks. The 50-day moving average sits at 4.55, while the 200-day moving average is 41.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -89.59184% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 41.73 |
| Average Volume (20 Days) | N/A |
Stock Splits
Psyence Biomedical Ltd.'s most recent stock split took place on February 2, 2026 with a 6:1 split ratio.
| Last Split Date | 2/2/2026 |
| Split Ratio | 6:1 |